p38 MAP kinase inhibitors
US8293748B2 · kind B2 · utility
44Cited by
4References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 2009 |
| Grant date | Oct 23, 2012 |
| Priority date | — |
| Expiry date | Oct 2, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are provided inter alia compounds of formula (I)wherein R1, Ar, L, X, R3 and Q are as defined in the specification for use in therapy, especially in the treatment of inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.